Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by high disease burden in some countries, as well as delays in reaching mortality targets due to the long natural history of disease progression to liver cirrhosis and hepatocellular carcinoma.
The Hepatitis C Trust: Peer-to-peer programme
This video provides an overview of The Hepatitis C Trust's peer-to-peer support work, which involves staff and volunteer peers with lived experience of hepatitis C providing support to those at risk of and living with hepatitis C, raising awareness and supporting access to testing and treatment.
